Zibotentan, an EDN1A antagonist, prevents A beta-induced hypertension, maintains cerebral perfusion, and may have therapeutic potential for Alzheimer's disease

Palmer, J; Tayler, HM; Dyer, L; Kehoe, PG; Paton, JFR; Love, S

BRAIN PATHOLOGY, 2019; 29 (): 73